CHESLEY TAFT & ASSOCIATES LLC – Regeneron Pharmaceuticals, Inc. Transaction History
CHESLEY TAFT & ASSOCIATES LLC portfolio value:
$334,000
portfolio value
CHESLEY TAFT & ASSOCIATES LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -54.20% | -574 shares | -292K | $688.87 | 485 |
| Q2 2022 | share | Increase | +2.92% | 30 shares | -111K | $591.13 | 1.05K |
| Q1 2022 | share | 0.00% | 0 shares | 87K | $698.42 | 1.02K | |
| Q4 2021 | share | Increase | +11.48% | 106 shares | 91K | $642.51 | 1.02K |
| Q3 2021 | share | 0.00% | 0 shares | 43K | $605.18 | 923 | |
| Q2 2021 | share | Decrease | -5.62% | -55 shares | 42K | $558.54 | 923 |
| Q1 2021 | share | Decrease | -16.62% | -195 shares | -93K | $473.14 | 978 |
| Q4 2020 | share | 0.00% | 0 shares | -90K | $483.11 | 1.17K | |
| Q3 2020 | share | Decrease | -20.37% | -300 shares | -262K | $559.78 | 1.17K |
| Q2 2020 | share | 0.00% | 0 shares | 200K | $623.65 | 1.47K | |
| Q1 2020 | share | Increase | +3.51% | 50 shares | 185K | $488.29 | 1.47K |
| Q4 2019 | share | Decrease | -2.20% | -32 shares | 130K | $375.48 | 1.42K |
| Q3 2019 | share | Increase | +13.85% | 177 shares | 4K | $277.4 | 1.45K |
| Q2 2019 | share | Decrease | -66.50% | -2.53K shares | -1.16M | $313 | 1.27K |
| Q1 2019 | share | Decrease | -0.96% | -37 shares | 128K | $410.62 | 3.81K |
| Q4 2018 | share | Decrease | -12.37% | -544 shares | -337K | $373.5 | 3.85K |
| Q3 2018 | share | 0.00% | 0 shares | 259K | $404.04 | 4.39K | |
| Q2 2018 | share | Decrease | -2.87% | -130 shares | -42K | $344.99 | 4.39K |
| Q1 2018 | share | Decrease | -1.61% | -74 shares | -170K | $344.36 | 4.52K |
| Q4 2017 | share | 0.00% | 0 shares | -328K | $375.96 | 4.6K | |
| Q3 2017 | share | Increase | 0.00% | 4.6K shares | 2.05M | $447.12 | 4.6K |